Terril Brothers, Inc. Organon & Co. Transaction History

Terril Brothers, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $384,004 - $471,818	-12,129 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $18,848 - $24,363	-619 Reduced 4.86%	12,129 $424,000
Q4 2021 Feb 07, 2022	SELL	$28.67 - $37.13 $146,159 - $189,288	-5,098 Reduced 28.57%	12,748 $388,000
Q3 2021 Oct 29, 2021	SELL	$28.63 - $35.64 $19,411 - $24,163	-678 Reduced 3.66%	17,846 $585,000
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $527,007 - $703,912	18,524 New	18,524 $561,000

786

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.04B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Terril Brothers, Inc., based on Form 13F filings with the SEC.

Stay updated on Terril Brothers, Inc. with notifications on news.